Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts

BACKGROUND: Market Access Agreements (MAA) between pharmaceutical industry and health care payers have been proliferating in Europe in the last years. MAA can be simple discounts from the list price or very sophisticated schemes with inarguably high administrative burden. DISCUSSION: We distinguishe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarosławski, Szymon, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203045/
https://www.ncbi.nlm.nih.gov/pubmed/21982545
http://dx.doi.org/10.1186/1472-6963-11-259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203045/
https://www.ncbi.nlm.nih.gov/pubmed/21982545
http://dx.doi.org/10.1186/1472-6963-11-259

Ejemplares similares